id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-1252-0002,FDA,FDA-2021-N-1252,"Panray Corp. Sub Ormont Drug and Chemical Co., Inc., et al.; Withdrawal of Approval of Three New Drug Applications",Notice,Withdrawal,2022-07-22T04:00:00Z,2022,7,,,2022-07-22T14:11:23Z,2022-15629,0,0,09000064851e1e8c
FDA-2021-N-1252-0001,FDA,FDA-2021-N-1252,"Panray Corp. Sub Ormont Drug and Chemical Co., Inc., et al.; Proposal To Withdraw Approval of Three New Drug Applications; Opportunity for a Hearing",Notice,Withdrawal,2021-12-27T05:00:00Z,2021,12,2021-12-27T05:00:00Z,2022-02-26T04:59:59Z,2021-12-27T14:24:54Z,2021-27946,0,0,0900006484efd6cc